Mobile lipid accumulation in necrotic tissue of high grade astrocytomas

Anticancer Research

Volumn 16, Issue 3 B, 1996, Pages 1485-1489

  Kuesel, A C ^a,d   Briere, K M ^a   Halliday, W C ^b   Sutherland, G R ^b,c   Donnelly, S M ^a   Smith, I C P ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b Health Sciences ^*  (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

Astrocytomas; Lipid; Necrotic tissue

Indexed keywords

ASTROCYTOMA; CANCER GRADING; CLINICAL ARTICLE; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID STORAGE; NECROSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ASTROCYTOMA; HUMANS; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; NECROSIS;

EID: 0030018479     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Scherer JH: Structural development in gliomas. Am J Cancer 34: 333-339, 1939.
2. Hoshino T: A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 61: 895-900, 1984.
3. Wikstrand CJ, Grahmann FC, McComb RD and Bigner DD: Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies. J Neuropath Exp Neurol 44: 229-241, 1985.
4. Daumas-Duport C, Scheithauer BW and Kelly PJ: A histologic and cytologic method for the spatial definition of gliomas. Mayo Clinic Proceedings 62: 435-449, 1987.
5. Mangiardi JR and Yodice P: Metabolism of the malignant astrocytoma. Neurosurg 26: 1-19, 1990.
6. 1H MRS of High Grade Astrocytomas: Mobile Lipid Accumulation in Necrotic Tissue. NMR Biomed 7: 149-155, 1994.
7. 1H MR Spectroscopy. NMR Biomed 7: 172-180, 1994.
8. Daumas-Duport C, Scheithauer B, O'Fallon J and Kelly P: Grading of astrocytomas. A simple and reproducible method. Cancer 62: 2152-2165, 1988.
9. Nelson JS, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J and Peress N: Necrosis as a Prognostic Criterion in Malignant Supratentorial Astrocytic Gliomas. Cancer 52: 550-554, 1983.
10. Ott D, Hennig J and Ernst T: Human brain tumors: Assessment with in vivo proton MR spectroscopy. Radiol 186: 745-752, 1993.
11. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BCP, Mengeot MM, Moser E, Padavic-Shaller KA Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K and Zimmerman RA: Proton MR spectroscopy in patients with glial tumors: A multicenter study. J. neurosurg 84: 449-458, 1995.
12. Mountford CE, Mackinnon WB, Burnell EE, Bloom M and Smith ICP: NMR methods for characterising the state of the surfaces of complex mammalian cells. J Biochem Biophys Meth 9: 323-330, 1984.
13. Callies R, Sri-Pathmanathan RM, Ferguson DYP and Brindle KM: The appearance of neutral lipid signals in the H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn Res Med 29: 546-550, 1993.
14. Freitas I, Pontiggia P, Barni S, Bertone V, Parente M, Novarina A, Roveta G, Gerzeli G and Stoward P: Histochemical probes for the detection of hypoxic tumour cells. Anticancer Res 10: 613-622, 1990.
15. 1H NMR spectroscopy. J Neurochem 64: 1655-1661, 1995.
16. Kuesel AC, Kroft T, Saunders JK, Prefontaine M, Mikhael N and Smith ICP: A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens: cervical biopsies. Magn Res Med 27: 340-345, 1992.
17. Delikatny EJ, Russel P, Hunter JC, Hancock R, Atkinson KH, Haaften-Day CV and Mountford CE: Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. Radiol 188: 791-796, 1993.
18. 1H NMR spectroscopy of colon tumors and normal mucosal biopsies: elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance. NMR Biomed 6: 118, 1993.
19. 1H MR visible lipids in colon tissue from normal and carcinogen-treated rats. NMR Biomed 8: 33-40, 1995.
20. 1H MRS: correlation with histopathology. Magn Res Med 30: 525-533, 1993.
21. 1H Magnetic Resonance Spectroscopy. Int J Cancer 59: 248-261, 1994.
22. Mountford CE, Grossman G, Reid G and Fox RM: Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy. Cancer Res 42: 2270-2276, 1982.
23. Dingley AJ, King NJC and King GF: An NMR Investigation of the Changes in plasma membrane triglyceride and phospholipid precursors during the activation of T-lymphocytes. Biochem 31: 9098-9106, 1992.